DE60229143D1 - Cyclopropyl und cyclobutyl epothilon analoge - Google Patents

Cyclopropyl und cyclobutyl epothilon analoge

Info

Publication number
DE60229143D1
DE60229143D1 DE60229143T DE60229143T DE60229143D1 DE 60229143 D1 DE60229143 D1 DE 60229143D1 DE 60229143 T DE60229143 T DE 60229143T DE 60229143 T DE60229143 T DE 60229143T DE 60229143 D1 DE60229143 D1 DE 60229143D1
Authority
DE
Germany
Prior art keywords
epothilon
analoge
cyclobutyl
cyclopropyl
cyclopropyl und
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60229143T
Other languages
English (en)
Inventor
Kyriacos Costa Nicolaou
Kenji Namoto
Andreas Ritzen
Trond Ulven
Mutsuru Shoji
Karl-Heinz Altmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of DE60229143D1 publication Critical patent/DE60229143D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silicon Polymers (AREA)
DE60229143T 2001-08-23 2002-08-22 Cyclopropyl und cyclobutyl epothilon analoge Expired - Fee Related DE60229143D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31469801P 2001-08-23 2001-08-23
PCT/EP2002/009407 WO2003018002A2 (en) 2001-08-23 2002-08-22 Cyclopropyl and cyclobutyl epothilone analogs

Publications (1)

Publication Number Publication Date
DE60229143D1 true DE60229143D1 (en) 2008-11-13

Family

ID=23221047

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60229143T Expired - Fee Related DE60229143D1 (en) 2001-08-23 2002-08-22 Cyclopropyl und cyclobutyl epothilon analoge

Country Status (13)

Country Link
US (1) US7358266B2 (de)
EP (2) EP2070534A3 (de)
JP (2) JP4176015B2 (de)
CN (1) CN100536841C (de)
AT (1) ATE409473T1 (de)
AU (1) AU2002331171A1 (de)
BR (1) BR0212107A (de)
CA (1) CA2456280A1 (de)
DE (1) DE60229143D1 (de)
ES (1) ES2315399T3 (de)
HK (1) HK1066464A1 (de)
PT (1) PT1420780E (de)
WO (1) WO2003018002A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6867305B2 (en) 1996-12-03 2005-03-15 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
WO1999001124A1 (en) * 1996-12-03 1999-01-14 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
DE60229143D1 (en) * 2001-08-23 2008-11-13 Novartis Ag Cyclopropyl und cyclobutyl epothilon analoge
ATE381569T1 (de) * 2002-08-02 2008-01-15 Novartis Pharma Gmbh Epothilonderivate
ES2281692T3 (es) * 2002-08-23 2007-10-01 Sloan-Kettering Institute For Cancer Research Sintesis de epotilones, sus intermediarios, sus analogos y sus usos.
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US7384964B2 (en) * 2002-08-23 2008-06-10 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US20050171167A1 (en) 2003-11-04 2005-08-04 Haby Thomas A. Process and formulation containing epothilones and analogs thereof
GB0405898D0 (en) 2004-03-16 2004-04-21 Novartis Ag Organic compounds
CN101535492A (zh) 2005-02-11 2009-09-16 南加州大学 表达含有二硫键的蛋白质的方法
AU2006318284A1 (en) * 2005-11-22 2007-05-31 The Scripps Research Institute Chemical synthesis of a highly potent epothilone
EP2029156A4 (de) * 2006-05-01 2010-07-21 Univ Southern California Kombinationstherapie zur krebsbehandlung
JP5115729B2 (ja) * 2008-06-20 2013-01-09 信越化学工業株式会社 トリアルキルシリル基で保護されたアセト酢酸エステル基含有有機ケイ素化合物及びその製造方法
WO2010056901A2 (en) 2008-11-13 2010-05-20 University Of Southern California Method of expressing proteins with disulfide bridges with enhanced yields and activity
WO2011146638A1 (en) 2010-05-18 2011-11-24 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases
CN115959978A (zh) * 2022-07-22 2023-04-14 北京先通国际医药科技股份有限公司 一种修饰长链脂肪酸型pet试剂前体的合成方法及其用途
CN115141087B (zh) * 2022-09-06 2023-03-24 北京先通国际医药科技股份有限公司 Pet前体关键中间体的异构体的合成方法及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5969145A (en) * 1996-08-30 1999-10-19 Novartis Ag Process for the production of epothilones and intermediate products within the process
US6441186B1 (en) * 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
US6380394B1 (en) * 1996-12-13 2002-04-30 The Scripps Research Institute Epothilone analogs
US6399638B1 (en) * 1998-04-21 2002-06-04 Bristol-Myers Squibb Company 12,13-modified epothilone derivatives
DE19848306A1 (de) * 1998-10-14 2000-04-20 Schering Ag Verfahren zur Herstellung von Epothilon B und Derivaten sowie Zwischenprodukte für dieses Verfahren
HUP0105330A2 (hu) * 1999-02-11 2002-05-29 Schering Ag. Epotilonszármazékok, eljárás előállításukra és gyógyszerészeti alkalmazásuk
DE60229143D1 (en) * 2001-08-23 2008-11-13 Novartis Ag Cyclopropyl und cyclobutyl epothilon analoge

Also Published As

Publication number Publication date
US20040039026A1 (en) 2004-02-26
CA2456280A1 (en) 2003-03-06
US7358266B2 (en) 2008-04-15
WO2003018002A3 (en) 2003-09-04
EP1420780B1 (de) 2008-10-01
JP2009007367A (ja) 2009-01-15
JP4176015B2 (ja) 2008-11-05
PT1420780E (pt) 2008-12-29
AU2002331171A1 (en) 2003-03-10
EP2070534A2 (de) 2009-06-17
WO2003018002A2 (en) 2003-03-06
CN100536841C (zh) 2009-09-09
EP2070534A3 (de) 2009-08-26
EP1420780A2 (de) 2004-05-26
ES2315399T3 (es) 2009-04-01
ATE409473T1 (de) 2008-10-15
CN1545411A (zh) 2004-11-10
BR0212107A (pt) 2004-08-24
HK1066464A1 (en) 2005-03-24
JP2005501107A (ja) 2005-01-13

Similar Documents

Publication Publication Date Title
DE60229143D1 (en) Cyclopropyl und cyclobutyl epothilon analoge
MXPA04000756A (es) Nuevos compuestos.
MY136430A (en) N-adamantylmethyl derivatives, pharmaceutical compositions containing them and processes for their preparation
MY129422A (en) Medicinal compounds
MXPA04005099A (es) Derivados de 5-sulfanil-4h-1,2,4-triazol y su uso como medicamento.
CA2400217A1 (en) Pteridine compounds for the treatment of psoriasis
WO2004026863A8 (en) Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors
HK1052009A1 (en) Novel thiazolo (4,5-D) pyrimidine compounds
HU229581B1 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
HK1087022A1 (en) Dpp-iv inhibitors
EP1256588A4 (de) Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediate zu beider herstellung
TW200616961A (en) Carbostyril compound
GB0114004D0 (en) Chemical compounds
NZ320580A (en) Tricyclic compounds, preparation and pharmaceutical compositions thereof
GB9305295D0 (en) Therapeutic compounds
SI1465625T1 (sl) Solubilizirani topoizomerazni strupi
GB0104050D0 (en) Chemical compounds
IL157653A0 (en) Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
GB0120461D0 (en) Novel compounds
AU4811396A (en) Substituted benzothienylpiperazines their use as medicaments, and processes for their preparation
AU5123296A (en) Epoxysuccinic acid derivatives
GB9912417D0 (en) Compounds useful in therapy
MXPA05007315A (es) Sintesis de (r) y (s)-aminocarnitina y derivados de esta de acido d- y l-aspartico.
WO2004074249A3 (en) Synthesis of peloruside a and analogs thereof for use as antitumor agents
WO2005056000A3 (fr) Substance neuroactive et utilisations d'une telle substance

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8339 Ceased/non-payment of the annual fee